Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

biomarker

  • Open Access
    Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
    HILLA TÖRMÄNEN, HEIKKI HUHTAMÄKI, TIINA HOLSTER, ULLA PUISTOLA, MIRJA PUOLAKKAINEN and ELINA URPILAINEN
    Anticancer Research June 2026, 46 (6) 3257-3265; DOI: https://doi.org/10.21873/anticanres.18195
  • You have access
    Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
    YUTA MURAI, KIICHI SUGIMOTO, TAKAHIRO IRIE, TAKASHI FUJISAKI, ATSUHIKO HAMADA, YUJI ANDO, SAKI KOCHI, MIYUKI TOAKE, YUKI NAKAGAWA, HIROMITSU TAKAHASHI, HIROTAKA MOMOSE, YUKI TSUCHIYA, RYOICHI TSUKAMOTO, HISASHI RO, KUMPEI HONJO, MAKOTO TAKAHASHI and ROBERT M. HOFFMAN
    Anticancer Research June 2026, 46 (6) 3267-3280; DOI: https://doi.org/10.21873/anticanres.18196
  • Open Access
    Cytometry by Time-of-Flight for Profiling Therapeutic Response in Colorectal Cancer: Strengths, Limitations, and Translational Challenges
    ELEANDROS KYROS, ADAM MYLONAKIS, PAGONA KASTANAKI, RALLIA-ILIANA VELLIOU, ANDREAS PANAGAKIS, SPYRIDON DAVAKIS, NIKOLETTA DIMITRIOU, EVANGELOS FELEKOURAS and ALEXANDROS PAPALAMPROS
    Anticancer Research May 2026, 46 (5) 2297-2316; DOI: https://doi.org/10.21873/anticanres.18118
  • Open Access
    Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
    YUKARI ADACHI, TAKERU MATSUDA, SACHIKO INUBUSHI, KEISUKE YASUDA, RYOTA ITO, NAOTO SHIRAKAMI, TAKAAKI TACHIBANA, MASAKI IMAI, HIROKI KAGIYAMA, TAKAO TSUNEKI, MASAYUKI ANDO, MASAFUMI SAITO, YUTAKA SUGITA, TARO IKEDA, YASUFUMI KOTERAZAWA, TOMOAKI AOKI, HITOSHI HARADA, YASUNORI OTOWA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, ROBERT M. HOFFMAN and YOSHIHIRO KAKEJI
    Anticancer Research May 2026, 46 (5) 2345-2352; DOI: https://doi.org/10.21873/anticanres.18121
  • You have access
    Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy
    YUKO TAMURA, MASANORI OSHI, HIROKI KONDO, KOHEI KASAHARA, SHO SATO, TAKASHI KOSAKA, HIROTOSHI AKIYAMA, CHIKARA KUNISAKI and ITARU ENDO
    Anticancer Research January 2026, 46 (1) 227-236; DOI: https://doi.org/10.21873/anticanres.17937
  • You have access
    Tumor Stroma Infiltrating T Cells Predict the Efficacy of Anti-CTLA-4 Antibody in NSCLC
    HIROSHI SAIJO, YOSHIHIKO HIROHASHI, TOSHIYUKI SUMI, NAOKI SHIJUBO, ASTUSHI SAITO, OSAMU HONJO, TOYOHIRO SAIKAI, HIROTSUGU TAKABATAKE, AKIHISA FUJITA, YASUHITO HONDA, HIROYUKI KOBA, HIROFUMI CHIBA and TOSHIHIKO TORIGOE
    Anticancer Research January 2026, 46 (1) 301-308; DOI: https://doi.org/10.21873/anticanres.17944
  • You have access
    The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
    SOICHI TAKEDA, TADASHI NAMISAKI, ARITOSHI KOIZUMI, HIROAKI TAKAYA, YUKI TSUJI, AKIHIKO SHIBAMOTO, SATOSHI IWAI, TAKASHI INOUE, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, SHINYA SATO, KOH KITAGAWA, KOSUKE KAJI, AKIRA MITORO, KIYOSHI ASADA and HITOSHI YOSHIJI
    Anticancer Research October 2025, 45 (10) 4493-4507; DOI: https://doi.org/10.21873/anticanres.17797
  • Open Access
    The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients
    LINDA KOKAINE, ZANDA DANEBERGA, MIHAILS ŠATCS, DANIELLA ZVINA, INGA NAĻIVAIKO, JURIJS NAZAROVS, ANDRIS GARDOVSKIS, MIKI NAKAZAWA-MIKLAŠEVIČA and EDVĪNS MIKLAŠEVIČS
    Anticancer Research September 2025, 45 (9) 3895-3912; DOI: https://doi.org/10.21873/anticanres.17748
  • Open Access
    microRNA in Chorioamnionitis: Emerging Biomarkers for Early Diagnosis
    CHIHIRO KIYOSHIMA, DAICHI URUSHIYAMA, KENICHI YOSHIKAWA, KOKO ISHIDA and FUSANORI YOTSUMOTO
    Anticancer Research August 2025, 45 (8) 3587-3594; DOI: https://doi.org/10.21873/anticanres.17721
  • You have access
    Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer
    HAN GYEOL KIM, SO YOUNG KANG, KYOUNG-MEE KIM, JI-YEON KIM, YEON HEE PARK, JIN SEOK AHN, YOUNG-HYUCK IM, YOOJOO LIM, SANGHOON SONG, KYUNGHYUN PAENG and EUN YOON CHO
    Anticancer Research June 2025, 45 (6) 2575-2586; DOI: https://doi.org/10.21873/anticanres.17629

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire